Advances in Research - Part 3
Home » News & Events » Advances in Research - Part 3 facebook

Jump to:  Viruses & Bacteria | Back to Index


PREVALENCE | Back to Index
      ADDM; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009 Dec 18;58(10):1-20.
      Baird G, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006 Jul 15; 368(9531):210-5.
      Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study. Arch Pediatr Adolesc Med. 2005 Jan;159(1):37-44.
      Bertrand J, et al. Prevalence of autism in a United States population: the Brick township, NJ, investigation. Pediatrics 2001; 108.
      Blaxill MF, Baskin DS, Spitzer WO. Blaxill, Baskin, and Spitzer on Croen et al. (2002), The changing prevalence of autism in California. J Autism Dev Disord. 2003 Apr;33(2):223-6; discussion 227-9.
      Byrd, Robert. MIND Institute. Report to the Legislature on the Principle Findings from The Epidemiology of Autism in California: A Compre-hensive Pilot Study.      UC Davis 17 Oct 2002.
      California Department of Developmental Services "Changes in the Population of Persons with Autism and Pervasive Developmental Disorders in California's Developmental Services System: 1987 through 1998." Report to the Legislature March 1, 1999:1-19.
      Croen L, et al. The changing prevalence of autism in California. J Autism Dev Disord. 2002 Jun;32(3):207-15.
      Croen LA, Grether JK. A Response to Blaxill, Baskin, and Spitzer on Croen et al. (2002), "The Changing Prevalence of Autism in California." J Autism Dev Disord, vol 33 April 2003, pp227-229(3).
      Hertz-Piccioto I, Delwiche L. The rise in autism and the role of age at diagnosis.      Epidemiology. 2009 Jan; 20(1): 84-90.
      Honda H, Shimizu Y, Imai M, Nitto Y. Cumulative incidence of childhood autism: a total population study of better accuracy and precision. Dev Med Child Neurol. 2005 Jan;47(1):10-8.
      Kadesjo B, Gillberg C, Hagberg B. Brief report: autism and Asperger syndrome in seven-year-old children: a total population study. J Autism Dev Disord. 1999 Aug;29(4):327-31.
      Lauritsen MB, Pedersen CB, Mortensen PB. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med. 2004 Oct;34(7):1339-46.
      Lotter V.; Epidemiology of autistic conditions in young children. I. Prevalence. Soc. Psychiatry 1966, 1; 124-137.
      Smeeth L, Cook C, Fombonne PE, Heavey L, Rodrigues LC, Smith PG, Hall AJ. Rate of first recorded diagnosis of autism and other pervasive developmental disorders in a United Kingdom general practice 1988 to 2001. BMC Med.      2004 Nov 9;2:39.
Yeargin-Allsopp M, et al. Prevalence of autism in a US metropolitan area. JAMA 2003 Jan 1;289(1)49-55.

      Atladóttir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders. J Autism Dev Disord. 2010 Apr 23.
      Caruso JM et al. Persistent preceding focal neurologic deficits in children with chronic Epstein-Barr virus encephalitis. J Child Neurol.      2000 Dec;15(12):791-6.
      Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. J Pediatr. 1978 Oct;93(4):699-703.
      DeLong GR, et al. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol.      1981 Mar;38(3):191-4.
      Dyken PR.      Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev. 2001;7(3):217-25.
      Ghaziuddin M et al. Autistic symptoms following herpes encephalitis. Eur Child Adolesc Psychiatry. 2002 Jun;11(3):142-6.
      Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol. 1991 Oct;33(10):920-4.
      Hornig M, Weissenbock H, Horscroft N, Lipkin WI. An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci USA 1999 Oct 12; 96(21):12102-7.
      Hornig M, Lipkin WI. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: Epidemiology, hypotheses, and animal models. Ment Retard Dev Disabil Res Rev 2001; 7(3):200-10.

      Ivarsson SA et al. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics. 1990 May;21(2):102-3.
      Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol. 2005 Feb;11(1):1-10.
      Lintas C, et al. Association of autism with polyomavirus infection in postmortem brains. J Neurovirol. 2010 Apr;16(2):141-9.
      Nicolson GL, Gan R, Nicolson NL, Haier J. Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders. J Neurosci Res. 2007 Apr;85(5):1143-8.
      Singh VK, Jensen RL. Elevated levels of measles antibodies in children with autism. Pediatr Neurol.      2003 Apr;28(4):292-4.
Sweeten TL, Posey DJ, McDougle CJ. Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord. 2004 Oct;34(5):583-6.